Physician profile
Mark Benjamin Currin
NPI 1821438441
$1,904.98
in general payments reported to CMS, 2019-2025
25 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.86 · 2020: $11.47 · 2021: $157 · 2022: $588 · 2023: $414 · 2024: $239 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $33.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.85 |
| Education | $33.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $265.81 | 2021-2023 | Speedicath |
| Medtronic, INC. | $265.01 | 2021-2025 | Interstim |
| Urogen Pharma, INC. | $208.83 | 2021-2025 | |
| Procept Biorobotics Corporation | $181.91 | 2022-2025 | |
| Rochester Medical Corporation | $148.44 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $99.79 | 2022-2025 | Bard Urinary Drainage Bag |
| Axonics, INC. | $84.82 | 2023-2024 | Bulkamid, Axonics |
| Teleflex LLC | $82.36 | 2023-2025 | Urolift |
| Sumitomo Pharma America, INC. | $64.38 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $63.09 | 2021-2025 | Axonics, General - Female Sui |
| Astellas Pharma US INC | $52.54 | 2022-2023 | Myrbetriq |
| Olympus America INC. | $38.68 | 2025 | Tecoflex, Olympus, Olympus |
| Ambu INC. | $38.40 | 2021 | |
| Laborie Medical Technologies Corp. | $37.86 | 2020-2025 | |
| Calyxo, INC. | $37.76 | 2025 | Cvac Aspiration System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $33.20 | 2023 | |
| Janssen Biotech, INC. | $30.83 | 2019-2025 | |
| Abbvie INC. | $25.34 | 2023 | Qulipta |
| 180 Medical, INC. | $23.67 | 2023 | |
| Immunitybio, INC. | $21.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.65 | 2023 | |
| Ferring Pharmaceuticals INC. | $20.02 | 2024 | Adstiladrin |
| Agiliti Surgical, INC. | $18.75 | 2024 | Soltive Superpulsed Laser, Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Abc Home Medical Supply, INC. | $15.30 | 2025 | |
| Alnylam Pharmaceuticals INC. | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Currin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.